Post co-culture with T cells, sorafenib treatment was observed to bolster T-cell IFN-γ release, triggering cytotoxic effects on NPC cells and fostering tumor cell apoptosis. The gene discussed is IFNG; the disease is nasopharyngeal carcinoma.